Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Blood-Based Proteomics for Deeper Insights into Indolent Systemic Mastocytosis: The Pioneer Trial Experience

Hussein A. Abbas, Annie Nguyen, Bofei Wang, Min Chen, Guang Yang, Ben Lampson, Rachel L. Erlich, Ivo Veletic

Blood (2024) 144 (Supplement 1): 6569.

https://doi.org/10.1182/blood-2024-205556

Published: 2024

Journal Articles

Addition of Inotuzumab Ozogamicin to Melphalan Plus Fludarabine Reduced-Intensity Conditioning Regimen of Allogeneic Transplantation in Patients with Acute Lymphoblastic Leukemia and Aggressive Lymphoid Malignancies: A Phase II Prospective Trial

Blood (2024) 144 (Supplement 1): 2124.

https://doi.org/10.1182/blood-2024-203864

Published: 2024

Journal Articles

Characteristics and Clinical Outcomes of Patients with Myeloid Malignancies and Cohesin Mutations

Maria Rita Khouri, Bofei Wang, Poorva Bindal, Sakiko Suzuki, Lloyd Hutchinson, Laurie K Pearson, Andrew Gillis-Smith, Jan Cerny, Muthalagu Ramanathan, Jonathan M. Gerber, Shyam Ajay Patel

Blood (2024) 144 (Supplement 1): 1553.

https://doi.org/10.1182/blood-2024-201680

Published: 2024

Journal Articles

Ten-Year Results of a Phase II Clinical Trial Evaluating Ipilimumab Plus Lenalidomide Combination after Autologous Hematopoietic Cell Transplantation in Patients with Lymphoma

Joseph E. Jabbour, Denái R. Milton, Alison M. Gulbis, Bofei Wang, Fadi G. Haddad, Celina Ledesma, Richard E. Champlin, Padmanee Sharma, Ken H. Young, Issa F. Khouri

Blood (2024) 144 (Supplement 1): 7250.

https://doi.org/10.1182/blood-2024-203392

Published: 2024

Journal Articles

Comprehensive Characterization of Inflammatory Cytokines in Chronic Lymphocytic Leukemia Highlight Immune Dysregulation and Associates with MRD

Bofei Wang, Jessica Lynn Root, Araceli Isabella Garza, Joyce Breaker, William G. Wierda, Hussein A. Abbas, Patrick K. Reville

Blood (2024) 144 (Supplement 1): 3236.

https://doi.org/10.1182/blood-2024-200843

Published: 2024

Journal Articles

ICASA: An Interactive Comprehensive Atlas of Single Cells in AML from 82 Bone Marrow Samples

Bofei Wang, Poonam N Desai, Jae Jun Ku, Naval Daver, Patrick K. Reville, Hussein A. Abbas

Blood (2024) 144 (Supplement 1): 2213.

https://doi.org/10.1182/blood-2024-202595

Published: 2024

Journal Articles

Blood-Based Proteomic Profiling Identifies Osmr As a Novel Biomarker

Hussein A. Abbas, Bofei Wang, Jennifer Marvin-Peek, Bin Yuan, Araceli Isabella Garza, Jessica Lynn Root, Andrea Arruda, Yiwei Liu, Courtney D. DiNardo, Tapan M. Kadia, Naval Daver, Philip L Lorenzi, Koji Sasaki, Steven M. Kornblau, Mark D. Minden, Farhad Ravandi, Hagop M. Kantarjian, Patrick K. Reville

Blood (2024) 144 (Supplement 1): 2912.

https://doi.org/10.1182/blood-2024-201725

Published: 2024

Journal Articles

Multi-Omic Analyses of TP53 -Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures

Jayakumar Vadakekolathu, Sarah Skuli, David J Boocock, Clare Coveney, Eruchi G Ikpo, Bofei Wang, Elena M Fenu, Hussein A. Abbas, Catherine E. Lai, Martin P Carroll, Sergio Rutella

Blood (2024) 144 (Supplement 1): 2911.

https://doi.org/10.1182/blood-2024-201311

Published: 2024

Journal Articles

Phase 1b/2 Study of Magrolimab (Magro), Azacitidine (AZA) and Venetoclax (VEN) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High Risk Acute Myeloid Leukemia (AML) and Relapsed Refractory (R/R) AML: Final Clinical Data and Genomic Markers of Resistance/Relapse

Blood (2024) 144 (Supplement 1): 735.

https://doi.org/10.1182/blood-2024-203706

Published: 2024

Journal Articles

Transcriptomic Signature of Resistance to Decitabine/Venetoclax in AML Patients

Abdullah Khasawneh, Faith Jessica Paran, Abhishek Maiti, Bofei Wang, Kala Hayes, Courtney D. DiNardo, Michael Andreeff, Hussein A. Abbas, Marina Konopleva, Yoko Tabe

Blood (2024) 144 (Supplement 1): 2766.

https://doi.org/10.1182/blood-2024-202806

Published: 2024

Journal Articles

Single Cell Profiling of Ph-Positive Acute Lymphoblastic Leukemias Reveals Distinct Cells of Origin

Sogand Sajedi, Nicholas J. Short, Enes Dasdemir, Bofei Wang, Cedric Nasnas, Elias Jabbour, Hagop M. Kantarjian, Patrick K. Reville, Hussein A. Abbas

Blood (2024) 144 (Supplement 1): 4219.

https://doi.org/10.1182/blood-2024-210997

Published: 2024

Journal Articles

IL-9 secreted by leukemia stem cells induces Th1-skewed CD4 + T cells, which promote their expansion

Ramin Radpour, Cedric Simillion, Bofei Wang, Hussein A. Abbas, Carsten Riether, Adrian F. Ochsenbein

Blood (2024) 144 (8): 888–903.

https://doi.org/10.1182/blood.2024024000

Published: 2024

Includes: Supplemental data

Journal Articles

Molecular Profiling of Response and Resistance to Venetoclax-Decitabine Therapy in Acute Myeloid Leukemia

Abdullah Khasawneh, Faith Jessica Paran, Rieko Oyama, Abhishek Maiti, Hussein A Abbas, Bofei Wang, Poonam N Desai, Kala Hayes, Joe R Harman, Xiaoping Su, Courtney D. DiNardo, Michael Andreeff, Thomas A Milne, Marina Y. Konopleva, Yoko Tabe

Blood (2023) 142 (Supplement 1): 4159.

https://doi.org/10.1182/blood-2023-180463

Published: 2023

Journal Articles

IFNγ Signaling in Acute Myeloid Leukemia Mediates Immunomodulation and Reveals Therapeutic Strategies

Blood (2023) 142 (Supplement 1): 2796.

https://doi.org/10.1182/blood-2023-175010

Published: 2023

Journal Articles

Single-Cell Polyfunctional Proteomic Profiling Reveals Temporal and Niche Differences in CD4 and CD8 T Cells in Acute Myeloid Leukemia Following PD-1 Blockade Therapy

Jessica Lynn Root, Poonam N Desai, Patrick K Reville, Christopher Ly, Bofei Wang, Fatima Z Jelloul, Jing Zhou, Sean Gregory Mackay, Mansour Alfayez, Jairo Matthews, Sherry Pierce, Naval Daver, Hussein A Abbas

Blood (2023) 142 (Supplement 1): 1584.

https://doi.org/10.1182/blood-2023-188268

Published: 2023

Journal Articles

Single-Cell Characterization of TP53-Mutated AML Patients Treated with Frontline Azacitidine, Venetoclax, and Magrolimab Reveals Mechanisms of Response and Resistance

Poonam N Desai, Bofei Wang, Patrick K Reville, Fatima Z Jelloul, Pamella Borges, Jayastu Senapati, Micah Castillo, Preethi Gunaratne, Naveen Pemmaraju, Tapan M. Kadia, Farhad Ravandi, Guillermo Garcia-Manero, Naval Daver, Hussein A Abbas

Blood (2023) 142 (Supplement 1): 64.

https://doi.org/10.1182/blood-2023-187307

Published: 2023

Journal Articles

Characterizing Inferred Functional and Phenotypical States of Newly Diagnosed Acute Myeloid Leukemia from Single Cell Transcriptomic Profiling

Bofei Wang, Christopher Ly, Enes Dasdemir, Fatima Z Jelloul, Poonam N Desai, Pamella Borges, Jessica Lynn Root, Guilin Tang, Preethi Gunaratne, Sreyashi Basu, Sonali Jindal, Yulong Chen, Khalida M Wani, Alexander J Lazar, Padmanee Sharma, Patrick K Reville, Hussein A Abbas

Blood (2023) 142 (Supplement 1): 2938.

https://doi.org/10.1182/blood-2023-178345

Published: 2023

Journal Articles

Single-Cell Profiling of CD8 Landscape in Treatment Naïve and Relapsed/Refractory AML Patients Reveals Distinct Effector Cellular States Predictive of Outcomes

Poonam Desai, Bofei Wang, Fatima Zahra Jelloul, Gheath Alatrash, Natalia Baran, Qing Deng, Michael R Green, Naval Daver, Marina Konopleva, Andy Futreal, Dapeng Hao, Hussein A Abbas

Blood (2022) 140 (Supplement 1): 9144–9145.

https://doi.org/10.1182/blood-2022-167225

Published: 2022

Journal Articles

Single Cell RNA-Seq Reveals Intra-Tumoral Heterogeneity Relevant to Differentiation States and Outcomes Among Newly Diagnosed Acute Myeloid Leukemia Patients

Bofei Wang, Fatima Zahra Jelloul, Pamella Borges, Poonam Desai, Guilin Tang, Marina Konopleva, Natalia Baran, Michael R Green, Qing Deng, Naval Daver, Andy Futreal, Dapeng Hao, Hussein A Abbas

Blood (2022) 140 (Supplement 1): 6272–6273.

https://doi.org/10.1182/blood-2022-167527

Published: 2022

NARROW

Blood-Based Proteomics for Deeper Insights into Indolent Systemic Mastocytosis: The Pioneer Trial Experience

Addition of Inotuzumab Ozogamicin to Melphalan Plus Fludarabine Reduced-Intensity Conditioning Regimen of Allogeneic Transplantation in Patients with Acute Lymphoblastic Leukemia and Aggressive Lymphoid Malignancies: A Phase II Prospective Trial

Characteristics and Clinical Outcomes of Patients with Myeloid Malignancies and Cohesin Mutations

Ten-Year Results of a Phase II Clinical Trial Evaluating Ipilimumab Plus Lenalidomide Combination after Autologous Hematopoietic Cell Transplantation in Patients with Lymphoma

Comprehensive Characterization of Inflammatory Cytokines in Chronic Lymphocytic Leukemia Highlight Immune Dysregulation and Associates with MRD

ICASA: An Interactive Comprehensive Atlas of Single Cells in AML from 82 Bone Marrow Samples

Blood-Based Proteomic Profiling Identifies Osmr As a Novel Biomarker

Multi-Omic Analyses of TP53 -Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures

Phase 1b/2 Study of Magrolimab (Magro), Azacitidine (AZA) and Venetoclax (VEN) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High Risk Acute Myeloid Leukemia (AML) and Relapsed Refractory (R/R) AML: Final Clinical Data and Genomic Markers of Resistance/Relapse

Transcriptomic Signature of Resistance to Decitabine/Venetoclax in AML Patients

Single Cell Profiling of Ph-Positive Acute Lymphoblastic Leukemias Reveals Distinct Cells of Origin

IL-9 secreted by leukemia stem cells induces Th1-skewed CD4 + T cells, which promote their expansion

Molecular Profiling of Response and Resistance to Venetoclax-Decitabine Therapy in Acute Myeloid Leukemia

IFNγ Signaling in Acute Myeloid Leukemia Mediates Immunomodulation and Reveals Therapeutic Strategies

Single-Cell Polyfunctional Proteomic Profiling Reveals Temporal and Niche Differences in CD4 and CD8 T Cells in Acute Myeloid Leukemia Following PD-1 Blockade Therapy

Single-Cell Characterization of TP53-Mutated AML Patients Treated with Frontline Azacitidine, Venetoclax, and Magrolimab Reveals Mechanisms of Response and Resistance

Characterizing Inferred Functional and Phenotypical States of Newly Diagnosed Acute Myeloid Leukemia from Single Cell Transcriptomic Profiling

Single-Cell Profiling of CD8 Landscape in Treatment Naïve and Relapsed/Refractory AML Patients Reveals Distinct Effector Cellular States Predictive of Outcomes

Single Cell RNA-Seq Reveals Intra-Tumoral Heterogeneity Relevant to Differentiation States and Outcomes Among Newly Diagnosed Acute Myeloid Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only